EE80 The Potential Clinical and Economic Benefits of a Next Generation Omicron-Containing (BA.1) Bivalent Sars-Cov-2 Booster Compared to First Generation Prototype Boosters in Germany Assuming BA.4/BA.5 Dominance
Abstract
Authors
M Maschio B Schweikert B Ultsch R Cai K Fust A Lee A Nasir P Buck N Van de Velde M Kohli